Reactive Oxygen Species Derived from NOX3 and NOX5 Drive Differentiation of Human Oligodendrocytes.
Reactive oxygen species (ROS) are signaling molecules that mediate stress response, apoptosis, DNA damage, gene expression and differentiation. We report here that differentiation of oligodendrocytes (OLs), the myelin forming cells in the CNS, is driven by ROS. To dissect the OL differentiation pathway, we used the cell line MO3-13, which display the molecular and cellular features of OL precursors. These cells exposed 1-4 days to low levels of H2O2 or to the protein kinase C (PKC) activator, phorbol-12-Myristate-13-Acetate (PMA) increased the expression of specific OL differentiation markers: the specific nuclear factor Olig-2, and Myelin Basic Protein (MBP), which was processed and accumulated selectively in membranes. The induction of differentiation genes was associated with the activation of ERK1-2 and phosphorylation of the nuclear cAMP responsive element binding protein 1 (CREB). PKC mediates ROS-induced differentiation because PKC depletion or bis-indolyl-maleimide (BIM), a PKC inhibitor, reversed the induction of differentiation markers by H2O2. H2O2 and PMA increased the expression of membrane-bound NADPH oxidases, NOX3 and NOX5. Selective depletion of these proteins inhibited differentiation induced by PMA. Furthermore, NOX5 silencing down regulated NOX3 mRNA levels, suggesting that ROS produced by NOX5 up-regulate NOX3 expression. These data unravel an elaborate network of ROS-generating enzymes (NOX5 to NOX3) activated by PKC and necessary for differentiation of OLs. Furthermore, NOX3 and NOX5, as inducers of OL differentiation, represent novel targets for therapies of demyelinating diseases, including multiple sclerosis, associated with impairment of OL differentiation.
Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II Naples, Italy.
Roberta
R
Accetta
Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II Naples, Italy.
Simona
S
Damiano
Laboratori di Ricerca Preclinica e Traslazionale, Istituto di Ricovero e Cura a Carattere Scientifico - Centro di Riferimento Oncologico della Basilicata Rionero in Vulture, Italy.
Annalisa
A
Morano
Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II Naples, Italy.
Paolo
P
Mondola
Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II Naples, Italy.
Roberto
R
Paternò
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II Naples, Italy.
Enrico V
EV
Avvedimento
Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II Naples, Italy.
Mariarosaria
M
Santillo
NOX3; NOX5; differentiation; multiple sclerosis; oligodendrocyte; reactive oxygen species